Glenmark Pharmaceuticals has informed about submission of a media release titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Topiramate Extended? Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’, which is self explanatory.
The above information is a part of company’s filings submitted to BSE.